GERNGeron Corporation

$1B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$460,000-56.8% YoY

Gross Profit

-$51M-11046.1% margin

Operating Income

-$73M-15762.0% margin

Net Income

-$69M-14901.7% margin

EPS (Diluted)

$-0.33

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$44M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$166M

Total Liabilities

$30M

Stockholders' Equity

$135M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$460,000	$1M	-56.8%
Gross Profit	-$51M	-$12M	-335.9%
Operating Income	-$73M	-$31M	-133.3%
Net Income	-$69M	-$27M	-153.7%

GERN FY 2019 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena